Kyongbo Pharmaceutical Company Overview
- Year Founded
-
1987
- Status
-
Public
- Employees
-
525
- Stock Symbol
-
214390
- Share Price
-
$3.66
- (As of Wednesday Closing)
Kyongbo Pharmaceutical Company General Information
Description
Kyongbo Pharmaceutical Co Ltd is a pharmaceutical company. It is involved in the business of manufacturing and sales of active pharmaceutical ingredient and finished drugs. Its products include Atorvastatin Calcium Hydrate, S-amlodipine Beslyate, Aripiprazole, Gaskhan and Kyongbo.
Contact Information
Website
www.kbpharma.co.krCorporate Office
- 174, Sirok-ro
- Asan, 31501
- South Korea
Corporate Office
- 174, Sirok-ro
- Asan, 31501
- South Korea
Kyongbo Pharmaceutical Company Stock Performance
As of 09-Jul-2025, Kyongbo Pharmaceutical Company’s stock price is $3.66. Its current market cap is $87.6M with 23.9M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.66 | $3.62 | $3.35 - $5.11 | $87.6M | 23.9M | 24.5K | $0.07 |
Kyongbo Pharmaceutical Company Financials Summary
As of 31-Mar-2025, Kyongbo Pharmaceutical Company has a trailing 12-month revenue of $170M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 149,528 | 158,866 | 213,253 | 225,745 |
| Revenue | 169,575 | 174,839 | 165,481 | 151,894 |
| EBITDA | 10,338 | 15,780 | 13,101 | 10,044 |
| Net Income | 1,645 | 3,400 | 2,275 | 473 |
| Total Assets | 195,532 | 192,731 | 206,649 | 190,469 |
| Total Debt | 66,885 | 62,074 | 58,926 | 51,082 |
Kyongbo Pharmaceutical Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kyongbo Pharmaceutical Company Patents
Kyongbo Pharmaceutical Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2420488-A1 | Novel crystalline form of atorvastatin hemi-calcium salt, hydrate thereof, and method of producing the same | Active | 28-Jul-2010 | ||
| EP-2420488-B1 | Novel crystalline form of atorvastatin hemi-calcium salt, hydrate thereof, and method of producing the same | Inactive | 28-Jul-2010 |
Kyongbo Pharmaceutical Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kyongbo Pharmaceutical Company ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Kyongbo Pharmaceutical Company FAQs
-
When was Kyongbo Pharmaceutical Company founded?
Kyongbo Pharmaceutical Company was founded in 1987.
-
Where is Kyongbo Pharmaceutical Company headquartered?
Kyongbo Pharmaceutical Company is headquartered in Asan, South Korea.
-
What is the size of Kyongbo Pharmaceutical Company?
Kyongbo Pharmaceutical Company has 525 total employees.
-
What industry is Kyongbo Pharmaceutical Company in?
Kyongbo Pharmaceutical Company’s primary industry is Drug Discovery.
-
Is Kyongbo Pharmaceutical Company a private or public company?
Kyongbo Pharmaceutical Company is a Public company.
-
What is Kyongbo Pharmaceutical Company’s stock symbol?
The ticker symbol for Kyongbo Pharmaceutical Company is 214390.
-
What is the current stock price of Kyongbo Pharmaceutical Company?
As of 09-Jul-2025 the stock price of Kyongbo Pharmaceutical Company is $3.66.
-
What is the current market cap of Kyongbo Pharmaceutical Company?
The current market capitalization of Kyongbo Pharmaceutical Company is $87.6M.
-
What is Kyongbo Pharmaceutical Company’s current revenue?
The trailing twelve month revenue for Kyongbo Pharmaceutical Company is $170M.
-
What is Kyongbo Pharmaceutical Company’s annual earnings per share (EPS)?
Kyongbo Pharmaceutical Company’s EPS for 12 months was $0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
